Abstract

Ibrutinib is used in the treatment of chronic myeloid leukemia. While patients taking the drug have developed rashes, there are few case reports and studies documenting this adverse effect. We present a case of rash associated with Ibrutinib therapy in a patient with chronic lymphocytic leukemia.

Author(s): Baby AP*, Hundal A, Aslam AD, Gade A, Laborde F, Ullah A, Singh J and Ahmed S

Abstract | Full-Text | PDF

Share This Article